Results 31 to 40 of about 2,047,581 (349)

Oral third-generation cephalosporins in the treatment of community-acquired urinary tract infections [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2019
Cephalosporins are one of the most commonly used antimicrobials for the treatment of variety of bacterial infections. Prudent use of the third-generation cephalosporins is important for the control of spread of cephalosporin-resistant Gram-negative ...
Kozlov R.S., Palagin I.S., Golub A.V.
doaj   +1 more source

Ceftazidimeavibactam use in children and adolescents [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2021
The increasing number of infections caused by multidrug-resistant gram-negative bacteria in children is a serious problem all over the world. Ceftazidim-avibactam is a promising antimicrobial drug recently approved in Russia for use in pediatric practice.
Stetsiouk О.U.   +3 more
doaj   +1 more source

AMRmap: an online platform for monitoring antibiotic resistance [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2017
This review describes the new Internet resource AMRmap (map.antibiotic.ru), which provides data on antibiotic resistance in the Russian Federation.
Kuzmenkov A.Yu.   +5 more
doaj  

Acinetobacter Non-baumannii Species: Occurrence in Infections in Hospitalized Patients, Identification, and Antibiotic Resistance

open access: yesAntibiotics, 2023
Background: Acinetobacter species other than A. baumannii are becoming increasingly more important as opportunistic pathogens for humans. The primary aim of this study was to assess the prevalence, species distribution, antimicrobial resistance patterns,
Eugene Sheck   +13 more
doaj   +1 more source

Nasopharyngeal carriage of Streptococcus pneumoniae in children from day-care centers in Smolensk [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2020
Objective. To investigate a nasopharyngeal carriage and serotypes of S. pneumoniae in children aged 3 to 6 years from day-care centers in Smolensk. Materials and Methods. A total of 245 isolates of S.
Zharkova L.P.   +3 more
doaj   +1 more source

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study

open access: yesJournal of Clinical Oncology, 2022
PURPOSE Pembrolizumab and pembrolizumab-chemotherapy demonstrated efficacy in recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048. Post hoc analysis of long-term efficacy and progression-free survival on next-line therapy (PFS2) is ...
K. Harrington   +20 more
semanticscholar   +1 more source

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

open access: yesNature, 2022
Standard first-line chemotherapy results in disease progression and death within one year in most patients with human epidermal growth factor receptor 2 (HER2)-negative gastro-oesophageal adenocarcinoma1–4.
K. Shitara   +28 more
semanticscholar   +1 more source

Antimicrobial resistance of nosocomial Enterobacteriaceae isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014 [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2017
Species of the family Enterobacteriaceae represent the most prevalent group of nosocomial pathogens. In this paper, we report the data on antimicrobial susceptibility of 1670 isolates of Enterobacteriaceae collected in 35 hospitals of 22 cities of Russia
Sukhorukova M.V.   +7 more
doaj  

First experience of using Brentuximab vedotin and modified program NHL-BFM-90 in the front-line treatment of patient with anaplastic large-cell lymphoma: a case report and a review of literature [PDF]

open access: yesТерапевтический архив, 2018
Nodal anaplastic ALK-negative large cell lymphoma (nALCL, ALK-) is a Т-cell lymphoma that is characterized by aggressive clinical course and low sensitivity to СНОР (cyclophosphamide, doxorubicin, vincristine, prednisolone) and other chemotherapy regimen.
N G CHERNOVA   +10 more
doaj   +1 more source

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

open access: yesBritish medical journal, 2022
Objective To evaluate sintilimab versus placebo in combination with chemotherapy (cisplatin plus paclitaxel or cisplatin plus 5-fluorouracil) as first line treatment of unresectable locally advanced, recurrent, or metastatic oesophageal squamous cell ...
Zhihao Lu   +29 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy